Transcription of Opioid Policy - Wa
{{id}} {{{paragraph}}}
Policy : Analgesics: Opioid Agonists Medical Policy No. Last Updated 03/31/2020 1 Analgesics: Opioid Agonists Medical Policy no. Effective November 1, 2019 Note: For non-preferred agents in this class/category, patients must have had an inadequate response or have had a documented intolerance due to severe adverse reaction or contraindication to at least TWO* preferred agents. *If there is only one preferred agent in the class/category documentation of inadequate response to ONE preferred agent is needed If a new-to-market drug falls into an existing class/category, the drug will be considered non-preferred and subject to this class/category prior authorization (PA) criteria Background: The Opioid agonists is a class of medications that is reserved for the treatment of severe pain that cannot be managed by non-pharmacologic therapies or other pharmacolo
Mar 31, 2020 · acting on opioid receptors in the central and peripheral nervous systems that block the sensation of pain from signaling to the brain. Opioid agonists are available in many dosage forms, including short-acting and long-acting formulations. Clinical policy: Drug Clinical Criteria (Initial Approval) Products approved by the FDA for
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}